L Gabriel Navar1. 1. Department of Physiology and the Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, New Orleans, Louisiana, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to provide an update on the current knowledge regarding the role of the intrarenal rennin-angiotensin system (RAS) in the regulation of glomerular function including glomerular dynamics and filtration rate, glomerular permeability and structural alterations during chronic increases in intrarenal angiotensin (Ang) II. RECENT FINDINGS: Recent studies have continued to delineate the complex interactions among the various RAS components that participate in regulating glomerular function. Although Ang II acting on AT1 receptors remains as the predominant influence on glomerular dynamics, some of these effects are indirectly mediated by Ang II modulating the sensitivity of the macula densa tubuloglomerular feedback mechanism as well as the more recently described feedback mechanism from the connecting tubule. Interestingly, the actions of Ang II on these systems cause opposite effects on glomerular function demonstrating the complexities associated with the influences of Ang II on glomerular function. When chronically elevated, Ang II also stimulates and/or interacts with other factors, including reactive oxygen species, cytokines and growth factors and other hormones or paracrine agents, to elicit structural alterations. SUMMARY: Recent studies have provided further evidence for the presence of many components of the RAS in glomerular structures, which supports the importance of locally produced angiotensin peptides to regulate glomerular haemodynamics, filtration rate and macromolecular permeability and contribute to fibrosis and glomerular injury when inappropriately augmented.
PURPOSE OF REVIEW: The purpose of this review is to provide an update on the current knowledge regarding the role of the intrarenal rennin-angiotensin system (RAS) in the regulation of glomerular function including glomerular dynamics and filtration rate, glomerular permeability and structural alterations during chronic increases in intrarenal angiotensin (Ang) II. RECENT FINDINGS: Recent studies have continued to delineate the complex interactions among the various RAS components that participate in regulating glomerular function. Although Ang II acting on AT1 receptors remains as the predominant influence on glomerular dynamics, some of these effects are indirectly mediated by Ang II modulating the sensitivity of the macula densa tubuloglomerular feedback mechanism as well as the more recently described feedback mechanism from the connecting tubule. Interestingly, the actions of Ang II on these systems cause opposite effects on glomerular function demonstrating the complexities associated with the influences of Ang II on glomerular function. When chronically elevated, Ang II also stimulates and/or interacts with other factors, including reactive oxygen species, cytokines and growth factors and other hormones or paracrine agents, to elicit structural alterations. SUMMARY: Recent studies have provided further evidence for the presence of many components of the RAS in glomerular structures, which supports the importance of locally produced angiotensin peptides to regulate glomerular haemodynamics, filtration rate and macromolecular permeability and contribute to fibrosis and glomerular injury when inappropriately augmented.
Authors: En Yin Lai; Glenn Solis; Zaiming Luo; Mattias Carlstrom; Kathryn Sandberg; Steven Holland; Anton Wellstein; William J Welch; Christopher S Wilcox Journal: Hypertension Date: 2011-12-19 Impact factor: 10.190
Authors: Qian Zhang; Lin Lin; Yan Lu; Haifeng Liu; Yanhua Duan; Xiaolong Zhu; Chengwei Zou; R Davis Manning; Ruisheng Liu Journal: Am J Physiol Renal Physiol Date: 2012-12-05
Authors: Peter Vavrinec; Robert H Henning; Maaike Goris; Diana Vavrincova-Yaghi; Hendrik Buikema; Richard P E van Dokkum Journal: Am J Physiol Renal Physiol Date: 2012-07-11
Authors: Chao Zhang; Xiaochen He; Sydney R Murphy; Huawei Zhang; Shaoxun Wang; Ying Ge; Wenjun Gao; Jan M Williams; Aron M Geurts; Richard J Roman; Fan Fan Journal: J Pharmacol Exp Ther Date: 2019-05-22 Impact factor: 4.030
Authors: Eric H J Verschuren; Charlotte Castenmiller; Dorien J M Peters; Francisco J Arjona; René J M Bindels; Joost G J Hoenderop Journal: Nat Rev Nephrol Date: 2020-03-03 Impact factor: 28.314
Authors: Gwendolyn K Davis; Suttira Intapad; Ashley D Newsome; Laura E Coats; Daniel R Bamrick; Norma B Ojeda; Barbara T Alexander Journal: Hypertension Date: 2019-08-05 Impact factor: 10.190
Authors: Guillaume L Hoareau; Timothy K Williams; Anders J Davidson; Rachel M Russo; Sarah-Ashley E Ferencz; Lucas P Neff; J Kevin Grayson; Ian J Stewart; M Austin Johnson Journal: Mil Med Date: 2019-05-01 Impact factor: 1.437